Copyright
©The Author(s) 2015.
World J Gastroenterol. Oct 14, 2015; 21(38): 10790-10810
Published online Oct 14, 2015. doi: 10.3748/wjg.v21.i38.10790
Published online Oct 14, 2015. doi: 10.3748/wjg.v21.i38.10790
Table 8 Distribution of hepatitis C virus genotypes among hepatitis C virus -infected patients in Iran n (%)
Study group | City or province | Location | Year of study | Sample size | Genotype 1 | Genotype 2 | Genotype 3 | Genotypes 4 and 5 | Mixed genotype | Non typable | Method | Author | Ref. |
Blood donors | Ahvaz | South-West | 2007-2008 | 45 | 1a: 24 (53.3) | 3a: 21 (46.7) | RFLP | Farshadpour | [233] | ||||
Blood donors | Tehran | North-Center | 2006-2008 | 103 | 1a: 53 (51.5) | 3a: 39 (37.9) | 7 (6.8) | Type-specific primers | Sharifi | [234] | |||
1b: 4 (3.9) | |||||||||||||
General population | Iran | Iran | 2000-2005 | 116 | 1a: 71 (61.2) | 3a: 29 (25.0) | RFLP | Amini | [235] | ||||
1b: 16 (13.8) | |||||||||||||
General population | Iran | Iran | 2004-2007 | 206 | 1a: 53 (25.73) | 2: 4 (1.95) | 3a: 96 (46.60) | 11 (5.34) | 6 (2.91) | PCR kit | Hajia | [236] | |
1b: 36 (17.47) | |||||||||||||
General population | Isfahan | Center | 2007-2009 | 97 | 1a: 29 (29.5) | 2: 2 (2.0) | 3a: 59 (61.2) | 2 (2.0) | PCR based genotyping kit | Zarkesh-Esfahani | [237] | ||
1b: 5 (5.1) | |||||||||||||
General population | Zanjan | West | 2007-2013 | ND | 1a: 22.05% | 2: 5.14% | 3a: 38.26% | 4: 4.41% | 4.41% | LiPA | Esmaeilzadeh | [238] | |
1b: 25.73% | |||||||||||||
General population | Yazd | Center | 2010-2013 | 191 | 1a: 74 (38.7) | 2: 3 (1.6) | 3: 96 (50.3) | 5 (2.6) | PCR based genotyping kit | Hadinedoushan | [239] | ||
1b: 13 (6.8) | |||||||||||||
General population | Mashhad | North-East | 2009-2010 | 382 | 1a: 147 (39.2) | 2a: 9 (2.4) | 3a: 150 (40.0) | 5: 13(3.4) | Genotype specific primers | Vossughinia | [240] | ||
1b: 41(10.9) | |||||||||||||
General population | Tehran | North-Center | 2007 | 2231 | 1a: 886 (39.7) | 3a: 613 (27.5) | 33 (1.6) | 401 (18.0) | Genotype specific primers | Keyvani | [241] | ||
1b: 271 (12.1) | |||||||||||||
General population | Golestan | North | 2010 | 77 | 1a: 15 (19.5) | 2a: 2 (2.6) | 3a: 12 (15.6) | 4: 6 (7.8) | 8 (6.5) | Genotype specific primers | Moradi | [242] | |
1b: 15(19.5) | 3b: 19 (24.7) | ||||||||||||
General population | Ahvaz | South-West | 2009 | 80 | 1a: 43 (53.8) | 3a: 37 (46.2) | RFLP | Hamidi-Fard | [243] | ||||
Thalassemia | Mazandaran | North | 2009-2011 | 34 | 1a: 13 (38.24) | 3a: 15 (44.12) | 4 (11.76) | 1 (2.94) | Type-specific primer | Rafiei | [244] | ||
1b: 1 (2.94) | |||||||||||||
Thalassemia | Mazandaran and Guilan | North | 2010 | 28 | 1a: 9 (32.1) | 3a: 18 (64.3) | RFLP | Ghane | [245] | ||||
1b: 1 (3.6) | |||||||||||||
Thalassemia | Fars | South | 2009-2012 | 38 | 1: 17 (44.7) | 3: 6 (15.8) | 15 (39.5) | Real-time PCR | Jamalidoust | [231] | |||
Haemophilia | Mazandaran | North | 2009-2011 | 33 | 1a: 7 (21.21) | 3a: 25 (75.76) | 1 (3.03) | Type-specific primer | Rafiei | [244] | |||
Haemophilia | Fars | South | 2009-2012 | 8 | 1: 5 (62.5) | 3: 1 (12.5) | 2 (25.0) | Real-time PCR | Jamalidoust | [231] | |||
Haemophilia | Ahvaz | South-West | 2008-2009 | 42 | 1a: 26 (61.9) | 3a: 5 (11.9) | Genotype specific primers | Assarehzadegan | [131] | ||||
1b: 11 (26.1) | |||||||||||||
Haemophilia | Markazi | West-Center | 2004 | 22 | 1: 6 (27.3) | 2: 1 (4.54) | 3a: 4 (18.2) | 6 (27.3) | LiPA | Samimi-Rad | [128] | ||
1a: 3 (13.6) | |||||||||||||
1b: 2 (9.1) | |||||||||||||
IDUs | Mazandaran | North | 2009-2011 | 37 | 1a: 11 (29.73) | 3a: 5 (13.51) | 11 (29.73) | Type-specific primer | Rafiei | [244] | |||
1b: 10 (27.03) | |||||||||||||
IDUs | Tehran | North-Center | 2008-2009 | 36 | 1a: 9 (25) | 3a: 21 (58.3 ) | Type-specific primers | Ranjbar Kermani | [246] | ||||
1b: 6 (16.7) | |||||||||||||
IDUs | Fars | South | 2009-2012 | 550 | 1: 283 (51.5) | 3: 192 (34.9) | 8 (12.2) | 67 (12.2) | Real-time PCR | Jamalidoust | [231] | ||
IDUs | Tehran | North-Center | 2008-2009 | 83 | 1a: 35 (42) | 3a: 48 (58.0) | Sequencing | Samimi-Rad | [247] | ||||
Haemodialysis | Mazandaran | North | 2009-2011 | 31 | 1a: 6 (19.36) | 3a: 24 (77.42) | 1 (3.22) | Type-specific primer | Rafiei | [244] | |||
Haemodialysis | Markazi | West-Center | 2005 | 8 | 1a: 4 (50) | 3a: 1 (12.5) | 4: 2 (25) | LiPA | Samimi-Rad | [102] | |||
1b: 1 (12.5) | |||||||||||||
Haemodialysis | Fars | South | 2009-2012 | 6 | 1: 4 (66.7) | 4: 1(16.7) | 1 (16.7) | Real-time PCR | Jamalidoust | [231] | |||
Haemodialysis | East Azerbaijan | North-West | 2006 | 55 | 1a: 42 (76.4) | 3a: 3 (5.5) | 1 (1.8) | 4 (10.9) | Type-specific primer | somi | [248] | ||
1b: 3 (5.5) | |||||||||||||
Haemodialysis | Gilan | North | 2008 | 32 | 1a: 19 (59.4) | 3a: 13 (40.6) | Genotype-specific primers | Joukar | [101] | ||||
Haemodialysis | Tehran | North-Center | 2004 | 66 | 1a: 19 (28.8) | 3a: 20 (30.3) | 4:11(16.7) | 2 (3.0) | RFLP | Hosseini-Moghaddam | [249] | ||
1b: 12 (18.2) | 3b: 2 (3.0) | ||||||||||||
HIV/HCV co-infection | Shiraz | South | 2004-2005 | 50 | 1a: 20 (40) | 3a: 17 (34.0) | RFLP | Davarpanah | [250] | ||||
1b: 13 (26) | |||||||||||||
Occult HCV infected patients | Tehran | North-Center | 2007-2010 | 7 | 1a: 2 (29) | 3a: 2 (29.0) | RFLP | Bokharaei-Salim | [251] | ||||
1b: 3 (43) |
- Citation: Taherkhani R, Farshadpour F. Epidemiology of hepatitis C virus in Iran. World J Gastroenterol 2015; 21(38): 10790-10810
- URL: https://www.wjgnet.com/1007-9327/full/v21/i38/10790.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i38.10790